Skip to main content
Top
Published in: Archives of Virology 9/2017

01-09-2017 | Brief Report

Vaccinia virus G1 protein: absence of autocatalytic self-processing

Authors: F. G. G. Leite, A. Bergthaler, T. Skern

Published in: Archives of Virology | Issue 9/2017

Login to get access

Abstract

Vaccinia virus relies on a series of proteolytic cleavage events involving two viral proteins, I7 and G1, to complete its life cycle. Furthermore, G1 itself is cleaved during vaccinia virus infection. However, convincing evidence is lacking to show whether G1 participates in autoproteolysis or is a substrate of another protease. We employed both biochemical and cell-based approaches to investigate G1 cleavage. G1, when expressed in bacteria, rabbit reticulocyte lysates or HeLa cells, was not processed. Moreover, G1 was cleaved in infected cells, but only in the presence of virus late gene expression; cleavage was strongly inhibited by proteasome inhibitors. Thus, these results imply a more complex G1 cleavage reaction than previously envisaged.
Literature
1.
go back to reference Aleshin AE, Drag M, Gombosuren N et al (2012) Activity, specificity, and probe design for the smallpox virus protease K7L. J Biol Chem 287:39470–39479CrossRefPubMedPubMedCentral Aleshin AE, Drag M, Gombosuren N et al (2012) Activity, specificity, and probe design for the smallpox virus protease K7L. J Biol Chem 287:39470–39479CrossRefPubMedPubMedCentral
2.
go back to reference Andrade AA, Silva PN, Pereira AC et al (2004) The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication. Biochem J 381:437–446CrossRefPubMedPubMedCentral Andrade AA, Silva PN, Pereira AC et al (2004) The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication. Biochem J 381:437–446CrossRefPubMedPubMedCentral
3.
go back to reference Ansarah-Sobrinho C, Moss B (2004) Vaccinia virus G1 protein, a predicted metalloprotease, is essential for morphogenesis of infectious virions but not for cleavage of major core proteins. J Virol 78:6855–6863CrossRefPubMedPubMedCentral Ansarah-Sobrinho C, Moss B (2004) Vaccinia virus G1 protein, a predicted metalloprotease, is essential for morphogenesis of infectious virions but not for cleavage of major core proteins. J Virol 78:6855–6863CrossRefPubMedPubMedCentral
4.
go back to reference Ansarah-Sobrinho C, Moss B (2004) Role of the I7 protein in proteolytic processing of vaccinia virus membrane and core components. J Virol 78:6335–6343CrossRefPubMedPubMedCentral Ansarah-Sobrinho C, Moss B (2004) Role of the I7 protein in proteolytic processing of vaccinia virus membrane and core components. J Virol 78:6335–6343CrossRefPubMedPubMedCentral
6.
go back to reference Bisht H, Weisberg AS, Szajner P, Moss B (2009) Assembly and disassembly of the capsid-like external scaffold of immature virions during vaccinia virus morphogenesis. J Virol 83:9140–9150CrossRefPubMedPubMedCentral Bisht H, Weisberg AS, Szajner P, Moss B (2009) Assembly and disassembly of the capsid-like external scaffold of immature virions during vaccinia virus morphogenesis. J Virol 83:9140–9150CrossRefPubMedPubMedCentral
10.
11.
14.
go back to reference Grimley PM, Rosenblum EN, Mims SJ, Moss B (1970) Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes. J Virol 6:519–533PubMedPubMedCentral Grimley PM, Rosenblum EN, Mims SJ, Moss B (1970) Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes. J Virol 6:519–533PubMedPubMedCentral
15.
go back to reference Hedengren-Olcott M, Byrd CM, Watson J, Hruby DE (2004) The vaccinia virus G1L putative metalloproteinase is essential for viral replication in vivo. J Virol 78:9947–9953CrossRefPubMedPubMedCentral Hedengren-Olcott M, Byrd CM, Watson J, Hruby DE (2004) The vaccinia virus G1L putative metalloproteinase is essential for viral replication in vivo. J Virol 78:9947–9953CrossRefPubMedPubMedCentral
16.
17.
go back to reference Jesus DM, Costa LT, Goncalves DL et al (2009) Cidofovir inhibits genome encapsidation and affects morphogenesis during the replication of vaccinia virus. J Virol 83:11477–11490CrossRefPubMedPubMedCentral Jesus DM, Costa LT, Goncalves DL et al (2009) Cidofovir inhibits genome encapsidation and affects morphogenesis during the replication of vaccinia virus. J Virol 83:11477–11490CrossRefPubMedPubMedCentral
18.
go back to reference Katritch V, Byrd CM, Tseitin V et al (2007) Discovery of small molecule inhibitors of ubiquitin-like poxvirus proteinase I7L using homology modeling and covalent docking approaches. J Comput Aided Mol Des 21:549–558CrossRefPubMed Katritch V, Byrd CM, Tseitin V et al (2007) Discovery of small molecule inhibitors of ubiquitin-like poxvirus proteinase I7L using homology modeling and covalent docking approaches. J Comput Aided Mol Des 21:549–558CrossRefPubMed
19.
go back to reference Moss B (2007) Poxviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, 5th edn. Lippincott Williams and Wilkins, New York, pp 2905–2945 Moss B (2007) Poxviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, 5th edn. Lippincott Williams and Wilkins, New York, pp 2905–2945
20.
go back to reference Neubauer D, Aumayr M, Gosler I, Skern T (2013) Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues. J Gen Virol 94:1535–1546CrossRefPubMedPubMedCentral Neubauer D, Aumayr M, Gosler I, Skern T (2013) Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues. J Gen Virol 94:1535–1546CrossRefPubMedPubMedCentral
21.
go back to reference Pereira AC, Leite FG, Brasil BS et al (2012) A vaccinia virus-driven interplay between the MKK4/7-JNK1/2 pathway and cytoskeleton reorganization. J Virol 86:172–184CrossRefPubMedPubMedCentral Pereira AC, Leite FG, Brasil BS et al (2012) A vaccinia virus-driven interplay between the MKK4/7-JNK1/2 pathway and cytoskeleton reorganization. J Virol 86:172–184CrossRefPubMedPubMedCentral
22.
go back to reference Pereira AC, Soares-Martins JA, Leite FG et al (2012) SP600125 inhibits Orthopoxviruses replication in a JNK1/2 -independent manner: Implication as a potential antipoxviral. Antiviral Res 93:69–77CrossRefPubMed Pereira AC, Soares-Martins JA, Leite FG et al (2012) SP600125 inhibits Orthopoxviruses replication in a JNK1/2 -independent manner: Implication as a potential antipoxviral. Antiviral Res 93:69–77CrossRefPubMed
23.
go back to reference Satheshkumar PS, Anton LC, Sanz P, Moss B (2009) Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes. J Virol 83:2469–2479CrossRefPubMedPubMedCentral Satheshkumar PS, Anton LC, Sanz P, Moss B (2009) Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes. J Virol 83:2469–2479CrossRefPubMedPubMedCentral
24.
go back to reference Schubert U, Ott DE, Chertova EN et al (2000) Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci USA 97:13057–13062CrossRefPubMedPubMedCentral Schubert U, Ott DE, Chertova EN et al (2000) Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci USA 97:13057–13062CrossRefPubMedPubMedCentral
25.
go back to reference Sivan G, Martin SE, Myers TG et al (2013) Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. Proc Natl Acad Sci USA 110:3519–3524CrossRefPubMedPubMedCentral Sivan G, Martin SE, Myers TG et al (2013) Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. Proc Natl Acad Sci USA 110:3519–3524CrossRefPubMedPubMedCentral
26.
go back to reference Soares JA, Leite FG, Andrade LG et al (2009) Activation of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required for both host survival and viral replication. J Virol 83:6883–6899CrossRefPubMedPubMedCentral Soares JA, Leite FG, Andrade LG et al (2009) Activation of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required for both host survival and viral replication. J Virol 83:6883–6899CrossRefPubMedPubMedCentral
27.
go back to reference Steinberger J, Grishkovskaya I, Cencic R et al (2014) Foot-and-mouth disease virus leader proteinase: structural insights into the mechanism of intermolecular cleavage. Virology 468–470:397–408CrossRefPubMedPubMedCentral Steinberger J, Grishkovskaya I, Cencic R et al (2014) Foot-and-mouth disease virus leader proteinase: structural insights into the mechanism of intermolecular cleavage. Virology 468–470:397–408CrossRefPubMedPubMedCentral
28.
go back to reference Taddie JA, Traktman P (1993) Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3′-5′ exonuclease domain. J Virol 67:4323–4336PubMedPubMedCentral Taddie JA, Traktman P (1993) Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3′-5′ exonuclease domain. J Virol 67:4323–4336PubMedPubMedCentral
29.
go back to reference Teale A, Campbell S, Van Buuren N et al (2009) Orthopoxviruses require a functional ubiquitin-proteasome system for productive replication. J Virol 83:2099–2108CrossRefPubMed Teale A, Campbell S, Van Buuren N et al (2009) Orthopoxviruses require a functional ubiquitin-proteasome system for productive replication. J Virol 83:2099–2108CrossRefPubMed
30.
Metadata
Title
Vaccinia virus G1 protein: absence of autocatalytic self-processing
Authors
F. G. G. Leite
A. Bergthaler
T. Skern
Publication date
01-09-2017
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 9/2017
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3409-y

Other articles of this Issue 9/2017

Archives of Virology 9/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.